Integrated BioPharma Balance Sheet Health
Financial Health criteria checks 6/6
Integrated BioPharma has a total shareholder equity of $19.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.2M and $7.0M respectively. Integrated BioPharma's EBIT is $251.0K making its interest coverage ratio -13.9. It has cash and short-term investments of $1.7M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -13.9x |
| Cash | US$1.68m |
| Equity | US$19.24m |
| Total liabilities | US$6.97m |
| Total assets | US$26.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INBP's short term assets ($17.9M) exceed its short term liabilities ($6.1M).
Long Term Liabilities: INBP's short term assets ($17.9M) exceed its long term liabilities ($846.0K).
Debt to Equity History and Analysis
Debt Level: INBP is debt free.
Reducing Debt: INBP has no debt compared to 5 years ago when its debt to equity ratio was 493.1%.
Debt Coverage: INBP has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: INBP has no debt, therefore coverage of interest payments is not a concern.